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This study aims at determining the epidemiologic, presenting symptoms, clinical 
course and electrophysiologic features of childhood Guillain-Barre Syndrome 
(GBS) in the East Azarbaijan province over a period of five years. 
Materials & Methods 
All the patients, aged< 15 years, referred/admitted to Tabriz Children Hospital 
with GBS between January 2001 and December 2005 were investigated.
Results 
One hundred and twelve subjects were enrolled during this period. The average 
annual incidence rate was 2.21 per 100000 population of children aged<15 
years (CI 95%: 1.8-2.6); the highest proportion of 29% was observed in winter 
(P=0.10); mean age (SD) of subjects was 5.1 (3.3) years, while 61.6% were ≤5 
years. The male/female ratio was 1.3. Antecedent events were identified in 80 
(71.4%) patients. The most common manifestation was limb weakness; at the 
peak of the disease course, only 8 (7.1%) patients were able to walk without 
assistance. Cranial nerve involvement was found in 37.5%. Fifteen percent of 
patients had autonomic dysfunction, and 32.2% complained of neuropathic 
pain. Artificial ventilation was needed in 10.7% of patients, and three patients 
(2.7%) died due to cardiac arrest. Electrophysiological examination showed the 
demyelinating type of the disease in 54.5%; axonal type in 35.7% and 9.8% as 
unclassified or normal pattern. Short time to reach nadir (P=0.008), cranial nerve 
involvement (P=0.000),) autonomic involvement (P=0.001), and axonal pattern 
on electro diagnosis (P=0.043) were found as risk factors for respiratory failure. 
In follow-up, at the end of one year, 95% of patients could walk without aid. 
Conclusion 
The axonal type of GBS is a relatively common form of childhood GBS occurring 
in East Azerbaijan.
Keywords: Guillian-Barre syndrome, Childhood, Epidemiology, Electrodiagnosis, 
Clinical features, East Azarbaijan
Introduction
Gullain-Barre syndrome (GBS) is an acute polyneuropathy which is most 
commonly characterized by rapidly progressive symmetric weakness and hypo or 
areflexia. It is now the main cause of acute flaccid paralysis in children (1). The 
annual incidence of typical GBS reported worldwide is between 0.6 and 4 cases (per 
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100000 populations) (2). 
Most previous studies report males as being more at risk 
than females (2-5). 
The syndrome is an autoimmune disease most frequently 
triggered by preceding infection. Many studies have 
reported that 50-75% of patients had had an infectious 
illness, 1-4 weeks prior to neurologic symptoms (2-
5). Overall, it is believed that GBS has a favorable 
course and prognosis; however a mortality rate of 
2-12 % has been reported. Some patients (4-30 %) 
may also require respiratory support (2-8).Therefore 
GBS patients seemingly require initial respiratory 
and autonomic monitoring to prevent fatal outcomes. 
Prompt recognition and optimal treatment of respiratory 
failure and autonomic dysfunction hence play key roles 
in successful management of the syndrome.
The GBS can be classified into the demyelinating and 
axonal types based on electrophysiological criteria (2). 
Frequency of the axonal form of GBS varies considerably 
in different countries, its incidence being less than 10% 
in Europe and North America, 65% in northern China, 
and 40% in Japan (9-11).
Majority of large studies on GBS in developed counties 
have focused on both children and adults. There are not 
many reports on pediatric GBS in Iran (12-13).
The purpose of this study was to document the 
epidemiologic data, clinical course and electrophysiologic 
features and outcome of childhood GBS in a defined 
geographic area in the Northwest of Iran. 
Materials & Methods
The setting of the study was Tabriz Children’s Hospital, 
the largest pediatric medical center in the Northwest of 
Iran; this 200-bed acute care university hospital provides 
tertiary referral care for critically ill patients. for this study, 
children must be <15 years old at the onset of weakness, 
and onset of disease should have been occurred during 
2001 to 2005. Inclusion criteria were age over <15 years 
at onset of weakness, and onset of disease should have 
occurred between 2001 and 2005.
As part of the World Health Organization (WHO) 
certification process for polio eradication, Iran has been 
systematically notifying/registering children under 
15 years old with acute flaccid paralysis since 1995. 
According to the local policy for acute flaccid paralysis 
(AFP) surveillance program, all cases of AFP must be 
referred to this hospital, where they are examined by 
an expert child neurologist (M.B.) within 7 days of 
notification. GBS is then diagnosed and ascertained 
based on the criteria defined by Asbury and Cornblath 
(1). One hundred and twelve cases of GBS were 
diagnosed and confirmed. Data recorded at admission, 
were: age, sex, and date of onset of the disease, 
preceding illness, clinical manifestation, and course of 
disease during hospitalization, results of CSF analysis 
and neurophysiologic evaluation, specific treatment and 
early outcome.
The functional status at the time of maximum deficit was 
graded according to Hughes scale of disability as follows: 
0: healthy, 1: minor signs and symptoms and ability 
to run; 2: ability to walk 5 meters without assistance, 
but unable to run. 3: ability to walk with assistance, 4: 
confined to bed or chair bound, 5: requiring assisted 
ventilation, and 6: died (14).
Poliovirus infection was excluded by cultures that are 
routinely performed for patients with acute flaccid 
paralysis as a requirement of the national program of 
poliomyelitis eradication in the country.
All children underwent at least one electrodiagnostic 
evaluation at the acute phase of disease, for which 
a Medelec Synergy electromyography machine was 
used. Nerve conduction studies included motor nerve 
conduction (MNC), sensory nerve conduction (SNC); 
F-wave response assessments were performed using the 
standard techniques while keeping the temperature under 
control. MNC studies were carried out on the ulnar, 
Median, tibial and deep peroneal nerves, and SNC on 
median and sural nerves. Each value of nerve conduction 
was compared with age matched normal data reported 
by Parano and colleagues (15). Needle EMG was done 
for any denervation potentials and motor unit action 
potentials (MUAP) changes in all patients in at least 
two proximal and two distal limb muscles. Patients were 
classified as having either the axonal or demyelinating 
type on the basis of the electro diagnostic criteria reported 
by Cornblath and colleagues (16); for each patient, the 
first neurophysiologic study was reviewed.
In addition to the general supportive management, 
specific therapy with 400 mg/kg of intravenous 
immunoglobulin for five days, were administered in 
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most cases. All patients followed until they achieved 
independent walking (maximum 12 months).
Data from the Ministry of Health, Statistics office, were 
used to estimate frequencies of the GBS in the region. 
Differences between proportions were statistically tested 
by Chi-square or Fisher’s exact test. All other numerical 
or quantitative comparisons were performed using 
student’s unpaired t-test or Mann-Whitney U test. All 
values were two tailed and were considered statistically 
significant if P ≤ 0.05. This study approved by the Ethics 
Committee of Tabriz University of Medical Sciences.
Results
Between 2001 and 2005 one hundred and twelve cases 
of GBS were diagnosed in Tabriz Children Hospital 
Occurrence of GBS (per 100 000) in the Northwest of 
Iran by year and gender is shown on table1. Based on 
data from the region’s general population, the average 
annul incidence rate was 2.22 per 100000 population of 
<15 years children (CI 95%: 1.8-2.6) ranging from 1.5 
to 3.4 in 2001 and 2003, respectively. The lowest and 
highest portion of the syndrome occurred in summer 
(21.4%) and winter (28.6%), respectively (P>0.10).
The most common manifestations in all subjects on 
admission were limb weakness, with various degrees 
of motor weakness, and areflexia or hyporeflexia. 
Demographic and clinical features of patients are 
presented in Table 2. The mean (SD) age of patients was 
5.1 (3.3) years, 61.4% of patients were aged ≤ 5 years. 
The sensory symptoms, mostly pain in the limbs were 
noted in 36 patients (32.2%). Because of younger age of 
most patients’, numbness and parasthesia were not very 
reliable. Cranial nerve involvement was found in 37.5% 
of patients. Bulbar weakness (hoarseness of voice, 
dysphonia, dysphagia, choking) (22.3%) were the most 
common type followed by facial palsy (17.9%). Only 8 
of 112 patients (7.1%) were able to walk independently 
at the peak of illness (grade 0-2). 
CSF studies were conducted in all patients (over the days 
1 to 16 of admission); levels of CSF total protein ranged 
between 10-850 mg/dl with white blood cell (WBC) 
count of 0-30 cells/mm3. The mean (SD) CSF protein 
concentration was 85.3(87.8) mg/dl while in 74.1% it 
was ≥ 40 mg/dl. In 25.9% of patients, whose CSF was 
obtained only in the first week of illness, protein levels 
were normal.
Neurophysiological examination was performed 1 to 
27 (mean 6.5days) days after the onset of weakness and 
usually near the peak of illness. Three patterns emerged: 
the demyelinating type (AIDP) in (54.5%) patients, the 
axonal type in (35.7%) patients and the unclassified or 
normal type in 9.8% of patients. Comparing the axonal 
and AIDP forms, no significant differences were found 
in the CSF protein levels, gender, clinical manifestation 
and age between axonal and AIDP forms. However 
the time taken to reach nadir was shorter in the axonal 
compared to the AIDP forms (mean ±SD): 4.2±2.7 vs. 
5.9±4.9 days (P=0.045). Axonal pattern was observed to 
be a risk factor for respiratory failure (P=0.043).
In addition to the general supportive management, 
specific therapy with 400 mg/kg of intravenous 
immunoglobulin for five days, was administered in 93 
patients, IVIG plus methyprednisolone succinate (20mg/
kg maximum 500mg) for five days administrated in 13 
patients; 6 patients received only supportive care due to 
unavailability of IVIG .
Autonomic involvement occurred in 17 (15.2%) patients 
including: cardiac arrhythmia in 7, hyper or hypotension 
in 5 patients, urinary incontinence in 3 and excessive 
sweating in 2 patients.
Twelve (10.7%) patients required mechanical ventilation 
for an average of 20.9 days (SD=20.8, and range: 1-75 
days). Risk factors for respiratory failure found were: 
short time to reach peak disability (P=0.008), cranial 
nerve involvement (P=0.0001),) autonomic involvement 
(P =0.001), and axonal pattern on electrodiagnosis 
(P=0.043). In 15 patients (13.4%), some complications, 
mostly pulmonary, occurred. In this study, three (2.7%) 
patients died due to cardiac arrest as a result of autonomic 
dysfunction. 
We evaluated the outcome at 6 months and 12 months 
of follow-up. At six months, 92.5 % of patients with the 
demeylinating form and 77.8% of patients with an axonal 
pattern, were able to walk independently (P=0.047). 
However, at end of 1 year, 95% of patients were capable 
of independent walking with no significant difference 
between two groups. 
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Table 1: Occurrence of Guillan-Barre syndrome (per 100 000) in the Northwest of Iran by year and gender
Total Frequency Rate Frequency Rate Frequency Rate
Year Population of GBS (100 000) CI 95% Male of GBS (100 000) CI 95% Female of GBS (100 000) CI 95%
2001 1003605 15 1.49 (0.7,2.3) 514399 10 1.94 (0.7,3.1) 489206 5 1.02 (0.1,1.9)
2002 1004684 20 1.99 (1.1,2.9) 514952 12 2.33 (1.0,3.6) 489732 8 1.63 (0.5,2.8)
2003 1004633 34 3.38 (2.2,4.5) 514926 16 3.11 (1.6,4.6) 489707 18 3.68 (2.0,5.4)
2004 1007195 22 2.18 (1.3,3.1) 516239 14 2.71 (1.3,4.1) 490956 8 1.63 (0.5,2.8)
2005 1018038 21 2.06 (1.2,2.9) 521796 12 2.3 (1.0,3.6) 496242 9 1.81 (0.6,3.0)
Total 5038155 112 2.22 (1.8,2.6) 2582311 64 2.48 (1.9,3.1) 2455843 48 1.95 (1.4,2.5)
Table 2:  Basic characteristics of the study subjects with Guillain-Barre syndrome
Mean Standard Deviation
Age (years) 5.1 3.3
























Cranial nerve Involvement 42 37.5
Autonomic dysfunction  17 15.2
Sensory symptoms pain (limbs) 36 32.2
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Discussion
This study reports the clinical and epidemiologic 
characteristics of GBS over a 5-year period, as observed 
at a large pediatric tertiary care center in the Northwest of 
Iran. The epidemiology of GBS is not easy to investigate 
because of the difficulties in case definition and the 
absence of a reference standard diagnostic test. Objective 
physiologic abnormalities of nerve dysfunction may also 
be difficult to detect in the early stages. 
In our study, the average incidence rate was 2.22 
per 100000 populations of children aged < 15 years, 
which was within the range reported from most areas 
worldwide (0.2-4 cases per 100000) (2-6, 8). In our area 
the incidence ranged between 1.5 and 3.5 in different 
years. A similar fluctuation of annual incidence of GBS 
has been reported in some studies (3, 17-19).
The syndrome occurred at all ages. However the age 
distribution showed that it predominantly affects children 
aged 1-5 years, which is consistent with the findings 
of some studies (5,20,21). In children the incidence of 
GBS may decrease by age while in adults it shows the 
opposite pattern. Immunological status and vulnerability 
of myelin in both early/late life may explain the increased 
susceptibility to GBS (22). The male to female ratio (1.3) 
in our study is in accordance with other reports (2-6,8 
,13,20,21 ).
Although the disease is considered to be sporadic without 
significant variation between seasons and months, small 
clustering of patients, in this study, during winter could 
be related the higher frequency of upper respiratory 
infections during the cold weather(winter). GBS is the 
prototypic post infectious disease with 50 to 75% of 
patients with an antecedent illness. Respiratory infection 
was the most frequently reported preceding illness, 
followed by gastrointestinal infections (2-6, 8, 20, 21). 
In our study, 71.4% of patients had a history of acute 
infectious illnesses preceding the onset of neurologic 
symptoms, including URI (56.3%) and GI infections in 
11.6% of cases.
No remarkable differences in clinical presentation were 
found between our findings and previously published 
reports (2-6, 8, 12, 13, 20, 21). However our case material 
shows a trend toward severe cases (71.4% were in grade 
≥4); mostly due to the availability of pediatric intensive 
care at our hospital. 
In a study on 254 patients conducted over 8 years, only 
4.7% were able to walk independently throughout their 
entire course of GBS (23). In our study this statistic was 
7%. In recent years, it has been shown that GBS includes 
at least two distinct conditions: acute demyelinating 
inflammatory polyneuropathy (AIDP) and acute motor or 
motor sensory axonal neuropathy (AMAN or AMSAN) 
(2). There have been some reports on the incidence of 
AIDP and axonal types of childhood GBS; the axonal 
pattern was found in up to 65% in China (9), 40% in 
Japan (10), 30% in Argentina (8), 35% in Turkey (24), 
31% in Pakistan (25) and 10% in North America (11). 
The percentage of cases with the axonal type in our 
study was higher than in western countries and lower 
than that of Chinese population; it is however consistent 
with figures of the axonal type GBS, observed in the 
neighboring countries (i.e. Turkey and Pakistan) and the 
Latin American regions. These findings suggest that the 
incidence of the axonal type in childhood GBS varies 
considerably among countries, the reason still unknown. 
However various populations have different genetic 
background and environmental exposures (2,9). On 
the other hand, differences in the frequency of various 
subtypes of GBS might be related to different sets for 
electrophysiologic identification of demyelination. At 
least 5 different sets of criteria have already been used 
by investigators (16, 26-29). We used the Cornblath set 
for this study.
Respiratory failure is the most serious short-term 
complication of GBS and may require invasive mechanical 
ventilation in 4-30% of patients (6-8). Moreover 60% 
of intubated patients developed major complications 
including pneumonia, sepsis, gastrointestinal bleeding 
and pulmonary embolism. Anticipation of respiratory 
failure is crucial to avoid respiratory distress and 
aspiration. In most studies, cranial nerve involvement 
especially bulbar weakness and time between onset of the 
disease and reaching peak disability was less than 7 days; 
electrophysiological evidence of axonal degeneration and 
vital capacity of less than 60% of that were considered 
as risk factors for developing respiratory failure (7,30-
31). In our study, the short time to reach peak disability, 
cranial nerve involvement, and autonomic involvement 
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were risk factors for developing respiratory failure. 
When patients with the normal or unclassified type are 
excluded, patients with axonal involvement are more 
likely to need assisted ventilation.
The prognosis of childhood GBS is generally favorable 
(5,8,20,21). In our study only 3 patients (2.7%) died. 
According to research reports, cardiac arrest, resulting 
from autonomic dysfunction, is the most common cause 
of death. Other causes of death include chest infection, 
pulmonary embolism and respiratory failure (6, 13, 27).
Long term outcomes of GBS are quite good, with an 
excellent functional recovery. Although in our study 
cranial nerve, autonomic involvement, rapid progression 
of illness and axonopathy were risk factors for a poor, 
early outcome (i.e. respiratory failure), these factors did 
not have adverse effects on long term outcomes. 
In conclusion,Epidemiological and clinical features of 
our subjects were relatively similar to those documented 
in other studies. The axonal type of GBS is a relatively 
common form of childhood GBS in East Azerbaijan, 
Iran. .Further studies are needed to investigate patterns 
of childhood GBS in other regions of Iran.
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